Faculty

32 1a 2a

61 16

Michael J Hogan, PhD

7 4 1 23

1f Graduate Group Affiliations 8

Cell and Molecular Biology
Immunology

46 Contact information
40

3800 Spruce Street
36 216A Rosenthal Bldg
Philadelphia, PA 19104

Email:
mihogan@upenn.edu

4 3 3 1d

18 Publications
23

96 6f

26 Search PubMed for articles c

3 2 4 b 1f

13 Education:
21 7 BS 19 (Biochemistry) c
29 Brown University, 2011.
21 8 PhD 27 (Cell and Molecular Biology) c
33 University of Pennsylvania, 2017.
c

3 27

Links
e2 Search PubMed for articles
4a Lab website
c

5 3 3 92 Permanent link
2 29

b6 > Perelman School of Medicine > Faculty > Details a

1e 1d

Description of Research Expertise

239 My research interests relate to understanding how protective immune responses are generated against viral diseases, with focuses on: the impact and mechanisms of unconventional T cell responses (e.g. non-classical MHC restriction, non-canonical open reading frames, and other unconventional epitopes), elucidating the interactions between CD4 T cells, CD8 T cells, and B cell responses to protect from viral illnesses, mechanisms of mRNA vaccine immunogenicity, and testing the immunogenicity of various mRNA vaccine designs in different animal species.
e 29

Selected Publications

18e Hogan, M. J., Maheshwari, N., Begg, B. E., Nicastri, A., Hedgepeth, E. J., Muramatsu, H., Pardi, N., Miller, M. A., Reilly, S. P., Brossay, L., Lynch, K. W., Ternette, N., Eisenlohr, L. C.: Cryptic MHC-E epitope from influenza elicits a potent cytolytic T cell response. Nature Immunology 24(11): 1933-1946, 2023.

c0 Hogan, M. J., Pardi, N.: mRNA vaccines in the COVID-19 pandemic and beyond. Annual Review of Medicine 73: 17-39, 2022.

c8 Verbeke, R., Hogan, M. J., Lore, K., Pardi, N.: Innate immune mechanisms of mRNA vaccines. Immunity 55(11): 1993-2005, 2022.

292 Saunders, K. O., Pardi, N., Parks, R., Santra, S., Mu, Z., Sutherland, L., Scearce, R., Barr, M., Eaton, A., Hernandez, G., Goodman, D., Hogan, M. J., Tombacz, I., Gordon, D. N., Rountree, R. W., Wang, Y., Lewis, M. G., Pierson, T. C., Barbosa, C., Tam, Y., Matyas, G. R., Rao, M., Beck, Z., Shen, X., Ferrari, G., Tomaras, G. D., Montefiori, D. C., Weissman, D., Haynes, B. F.: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates. npj Vaccines 6(1): 50, 2021.

cc Pardi, N., Hogan, M. J., Weissman, D.: Recent advances in mRNA vaccine technology. Current Opinion in Immunology 65: 14-20, 2020.

22e Lederer, K., Castano, D., Gomez Atria, D., Oguin, T. H., 3rd, Wang, S., Manzoni, T. B., Muramatsu, H., Hogan, M. J., Amanat, F., Cherubin, P., Lundgreen, K. A., Tam, Y. K., Fan, S. H. Y., Eisenlohr, L. C., Maillard, I., Weissman, D., Bates, P., Krammer, F., Sempowski, G. D., Pardi, N., Locci, M.: SARS-CoV-2 mRNA vaccines foster potent antigen-specific germinal center responses associated with neutralizing antibody generation. Immunity 53(6): 1281-1295 e5, 2020.

360 Laczko, D., Hogan, M. J., Toulmin, S. A., Hicks, P., Lederer, K., Gaudette, B. T., Castano, D., Amanat, F., Muramatsu, H., Oguin, T. H., 3rd, Ojha, A., Zhang, L., Mu, Z., Parks, R., Manzoni, T. B., Roper, B., Strohmeier, S., Tombacz, I., Arwood, L., Nachbagauer, R., Kariko, K., Greenhouse, J., Pessaint, L., Porto, M., Putman-Taylor, T., Strasbaugh, A., Campbell, T. A., Lin, P. J. C., Tam, Y. K., Sempowski, G. D., Farzan, M., Choe, H., Saunders, K. O., Haynes, B. F., Andersen, H., Eisenlohr, L. C., Weissman, D., Krammer, F., Bates, P., Allman, D., Locci, M., Pardi, N.: A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice. Immunity 53(4): 724-732 e7, 2020.

1e8 Bresk, C. A., Hofer, T., Wilmschen, S., Krismer, M., Beierfuss, A., Effantin, G., Weissenhorn, W., Hogan, M. J., Jordan, A. P. O., Gelman, R. S., Montefiori, D. C., Liao, H. X., Schmitz, J. E., Haynes, B. F., von Laer, D., Kimpel, J.: Induction of tier 1 HIV neutralizing antibodies by envelope trimers incorporated into a replication competent vesicular stomatitis virus vector. Viruses 11(2), 2019.

1bc Hogan, M. J., Conde-Motter, A., Jordan, A. P. O., Yang, L., Cleveland, B., Guo, W., Romano, J., Ni, H., Pardi, N., LaBranche, C. C., Montefiori, D. C., Hu, S. L., Hoxie, J. A., Weissman, D.: Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization. Virology 514: 106-117, 2018.

337 Pardi, N., Hogan, M. J., Naradikian, M. S., Parkhouse, K., Cain, D. W., Jones, L., Moody, M. A., Verkerke, H. P., Myles, A., Willis, E., LaBranche, C. C., Montefiori, D. C., Lobby, J. L., Saunders, K. O., Liao, H. X., Korber, B. T., Sutherland, L. L., Scearce, R. M., Hraber, P. T., Tombacz, I., Muramatsu, H., Ni, H., Balikov, D. A., Li, C., Mui, B. L., Tam, Y. K., Krammer, F., Kariko, K., Polacino, P., Eisenlohr, L. C., Madden, T. D., Hope, M. J., Lewis, M. G., Lee, K. K., Hu, S. L., Hensley, S. E., Cancro, M. P., Haynes, B. F., Weissman, D.: Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. Journal of Experimental Medicine 215(6): 1571-1588, 2018.

e0 Pardi, N., Hogan, M. J., Porter, F. W., Weissman, D.: mRNA vaccines - a new era in vaccinology. Nature Reviews: Drug Discovery 17(4): 261-279, 2018.

2e1 Pardi, N., Hogan, M. J., Pelc, R. S., Muramatsu, H., Andersen, H., DeMaso, C. R., Dowd, K. A., Sutherland, L. L., Scearce, R. M., Parks, R., Wagner, W., Granados, A., Greenhouse, J., Walker, M., Willis, E., Yu, J. S., McGee, C. E., Sempowski, G. D., Mui, B. L., Tam, Y. K., Huang, Y. J., Vanlandingham, D., Holmes, V. M., Balachandran, H., Sahu, S., Lifton, M., Higgs, S., Hensley, S. E., Madden, T. D., Hope, M. J., Kariko, K., Santra, S., Graham, B. S., Lewis, M. G., Pierson, T. C., Haynes, B. F., Weissman, D.: Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature 543(7644): 248-251, 2017.

189 Boyd, D. F., Peterson, D., Haggarty, B. S., Jordan, A. P., Hogan, M. J., Goo, L., Hoxie, J. A., Overbaugh, J.: Mutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer. Journal of Virology 89(2): 894-907, 2015.

2c

7 1d

2c back to top
26 Last updated: 04/21/2024
34 The Trustees of the University of Pennsylvania c

1 49 2 2 1a 32 34